Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma.

about

Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q49477746

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Signature of survival: a 18F-F ...... for hepatocellular carcinoma.

@en

Signature of survival: a 18F-F ...... for hepatocellular carcinoma.

@nl

type

Item

label

Signature of survival: a 18F-F ...... for hepatocellular carcinoma.

@en

Signature of survival: a 18F-F ...... for hepatocellular carcinoma.

@nl

prefLabel

Signature of survival: a 18F-F ...... for hepatocellular carcinoma.

@en

Signature of survival: a 18F-F ...... for hepatocellular carcinoma.

@nl

P1476

Signature of survival: a 18F-F ...... for hepatocellular carcinoma.

@en

P2093

Alban Denys

http://www.w3.org/2001/XMLSchema#string

Marie Nicod-Lalonde

http://www.w3.org/2001/XMLSchema#string

Marina Silva-Monteiro

http://www.w3.org/2001/XMLSchema#string

Mario Jreige

http://www.w3.org/2001/XMLSchema#string

Paul Blanc-Durand

http://www.w3.org/2001/XMLSchema#string

P2860

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

Radiomics: extracting more information from medical images using advanced feature analysis

[18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.

Global cancer statistics, 2012

THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL

Regularization Paths for Generalized Linear Models via Coordinate Descent

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data.

Decoding global gene expression programs in liver cancer by noninvasive imaging.

Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.

P304

4549-4558

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23423

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29435123

http://www.w3.org/2001/XMLSchema#string

P932

5796994

http://www.w3.org/2001/XMLSchema#string